{"text": ["3", "Top", "Pharma", "Stocks", "With", "Dividend", "Yields", "Over", "3%"], "created_at": "2018-02-27 22:33:00"}
{"text": ["Pfizer", "Gets", "Mixed", "Feedback", "on", "Cancer", "Treatments", "From", "CHMP"], "created_at": "2018-02-27 17:12:59"}
{"text": ["Pfizer", "Gets", "Mixed", "Feedback", "on", "Cancer", "Treatments", "From", "CHMP"], "created_at": "2018-02-27 17:12:59"}
{"text": ["3", "Reasons", "AbbVie", "Inc.", "Stock", "Could", "Keep", "Soaring", "in", "2018"], "created_at": "2018-02-27 15:08:54"}
{"text": ["3", "Reasons", "AbbVie", "Inc.", "Stock", "Could", "Keep", "Soaring", "in", "2018"], "created_at": "2018-02-27 15:08:54"}
{"text": ["ABBV", "Crosses", "Above", "Average", "Analyst", "Target"], "created_at": "2018-02-27 15:08:18"}
{"text": ["ABBV", "Crosses", "Above", "Average", "Analyst", "Target"], "created_at": "2018-02-27 15:08:18"}
{"text": ["Pfizer", "Gets", "Mixed", "Feedback", "on", "Cancer", "Treatments", "From", "CHMP"], "created_at": "2018-02-27 14:38:02"}
{"text": ["3", "Reasons", "AbbVie", "Inc.", "Stock", "Could", "Keep", "Soaring", "in", "2018"], "created_at": "2018-02-27 14:06:00"}
